Skip to main content
Log in

Rapid-onset pulmonary arterial hypertension in a patient with acute lymphoblastic leukemia treated with dasatinib

Schnell fortschreitende pulmonale arterielle Hypertonie bei einem Patienten mit akuter lymphoblastischer Leukämie bei Dasatinibbehandlung

  • e-Herz: Case study
  • Published:
Herz Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Kantarjian H, Shah NP, Hochhaus A et al (2010) Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 362:2260–2270

    Article  PubMed  CAS  Google Scholar 

  2. Fielding AK (2011) Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2011:231–237

    Article  PubMed  Google Scholar 

  3. Bergeron A, Rea D, Levy V et al (2007) Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. Am J Respir Crit Care Med 176:814–818

    Article  PubMed  CAS  Google Scholar 

  4. Montani D, Bergot E, Günther S et al (2012) Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 125:2128–2137

    Article  PubMed  CAS  Google Scholar 

  5. Orlandi EM, Rocca B, Pazzano AS, Ghio S (2012) Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia. Leuk Res 36:e4–e6

    Article  PubMed  Google Scholar 

  6. Dumitrescu D, Seck C, ten Freyhaus H et al (2011) Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia. Eur Respir J 38:218–220

    Article  PubMed  CAS  Google Scholar 

  7. Rasheed W, Flaim B, Seymour JF (2009) Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia. Leuk Res 33:861–864

    Article  PubMed  Google Scholar 

  8. Hennigs JK, Keller G, Baumann HJ et al (2011) Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? BMC Pulm Med 11:30

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Schermuly RT, Dony E, Ghofrani HA et al (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115:2811–2821

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Pullamsetti SS, Berghausen EM, Dabral S et al (2012) Role of SRC tyrosine kinases in experimental pulmonary hypertension. Arterioscler Thromb Vasc Biol 32:1354–1365

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S.-H. Shin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, JC., Shin, SH., Yi, H. et al. Rapid-onset pulmonary arterial hypertension in a patient with acute lymphoblastic leukemia treated with dasatinib. Herz 38, 931–933 (2013). https://doi.org/10.1007/s00059-013-3765-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-013-3765-7

Keywords

Navigation